The World Leader in Diffused Neutralizing Sanitizing Lighting
We are engineering the future of infection prevention. From hospitals to public spaces, our patented technology addresses the $100B+ global crisis of Healthcare-Acquired Infections.
The Silent Pandemic
The post-pandemic reality has exposed the vulnerability of indoor spaces. As global standards bodies like the WHO and CDC raise clean air targets, the world needs engineered prevention, not just reactive cleaning.
Key Statistics:
- 10 Million+: Annual cases of Healthcare-Acquired Infections (HAIs) globally.
- $100 Billion+: Annual economic burden on healthcare systems.
- Higher Mortality: HAIs currently kill more people annually than car accidents.
Cleaner air means safer spaces.
Our Solution Platform
Illumisoft is a lighting technology company specializing in infection prevention. We hold 19+ patents and offer a multi-tiered platform addressing a $248B market opportunity.
Sanilume
(Upper-Room GUV)
The world’s most effective upper-room GUV device. Capable of neutralizing pathogens at a rate equivalent to over 1,900 air changes per hour, offering protection levels vastly superior to standard competitive units.
- Status: Commercially available, Health Canada registered.
SaniLux
(Far-UVC 222nm)
The Breakthrough. Proprietary nanoparticle technology that is 70x more powerful than existing solutions. Safe for continuous human exposure, it eliminates pathogens in under one minute.
- Status: Disruptive innovation in development (12-18 months to commercial).
ECOWing (LED)
The Foundation. Top 4 globally-ranked efficiency and glare control. Provides the energy-saving infrastructure that powers our disinfection platforms.
- Status: Commercially available and DLC listed.
Validated by Science
Proven Performance, Rigorous Standards
"Best performing UV device tested to date."
Validation Points:
- 99.7% Pathogen Reduction: Validated in controlled aerobiology chambers.
- Regulatory Firsts: The first Upper-Room GUV device registered by Health Canada.
- Dr. David Brenner's Vision: Leveraging the research of the Columbia University pioneer who proved Far-UVC is safe for human skin and eyes.
Global Resilience & Mission
Not Just a Product, Civilizational Resilience
Concept: We are building infrastructure for the future. From the “Disease X” warnings by the WHO to the crisis of Antimicrobial Resistance (AMR), Illumisoft provides the proactive defense needed to keep schools, hospitals, and economies open.
Backed by Visionaries: Supported by Chris Anderson (Founder of TED) and Rob Reid, our mission is to implement technologies that ensure global continuity during future outbreaks.
Investor Snapshot
- Capturing a $248B Market Opportunity
Illumisoft is positioned at the intersection of a massive market need and a breakthrough technological solution. With a capital-light licensing model and high-margin production, we are scaling to meet global demand.
